Page last updated: 2024-11-04

sulfamethoxazole and Arthritis, Juvenile Chronic

sulfamethoxazole has been researched along with Arthritis, Juvenile Chronic in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Two months later, Pneumocystis carinii pneumonia developed."1.29Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. ( De Benedetti, F; Martini, A; Ravelli, A; Viola, S, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ravelli, A1
De Benedetti, F1
Viola, S1
Martini, A1

Other Studies

1 other study available for sulfamethoxazole and Arthritis, Juvenile Chronic

ArticleYear
Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.
    The Journal of pediatrics, 1996, Volume: 128, Issue:2

    Topics: Anti-Infective Agents; Antirheumatic Agents; Arthritis, Juvenile; Bone Marrow; Child; Cyclosporine;

1996